GSKGSK
13F holders, Q3 2024 (September 30)7holders
0new positions
0sold out
$40.80avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding GSK PLC (GSK) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Kahn Brothers Group Inc. ($43.3M), Eagle Asset Management Inc. ($675K) and Columbia Asset Management ($373K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q3 2024)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 1,893 shares bought and 182,819 shares sold, net −180,926 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Kahn Brothers Group Inc. | 7.46% | Reduce -14.7% | 1,058,832 | $43.3M |
| Eagle Asset Management Inc. | 0.00% | Add +11.3% | 18,610 | $675K |
| Columbia Asset Management | 0.07% | Add +0.1% | 9,130 | $373K |
| Paradigm Asset Management Co. LLC | 0.02% | Reduce -16.7% | 1,500 | $61K |
| PARK CIRCLE Co | 0.03% | No change | 800 | $33K |
| Byrne Asset Management LLC | 0.00% | Reduce -61.6% | 56 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.